Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: ACADIA Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ACADIA Pharmaceuticals Inc. May 29, 202488.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2025 | ACADIA Pharmaceuticals Inc. | Option exercise | +9,387 | — | — |
| May 29, 2024 | ACADIA Pharmaceuticals Inc. | Option exercise | +6,652 | — | — |
| Aug 1, 2023 | DBV Technologies S.A. | Open-market purchase | +15,000 | $1.62 | $24,300 |
| Jun 1, 2023 | ACADIA Pharmaceuticals Inc. | Option exercise | +8,552 | — | — |
| Jun 7, 2022 | ACADIA Pharmaceuticals Inc. | Option exercise | +6,391 | — | — |
| Jun 22, 2021 | ACADIA Pharmaceuticals Inc. | Option exercise | +3,059 | — | — |
Questions about Daniel B. Soland
What boards is Daniel B. Soland on?
Daniel B. Soland sits on the boards of ACADIA Pharmaceuticals Inc. and DBV Technologies S.A.
How long has Daniel B. Soland served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.